glp-1 receptor agonist antipsychotic weight gain study agonists are not just weight-loss drugs. They sit at the intersection of metabolism, inflammation, neuroplasticity, and cognition. That is why their relevance to metabolic psychiatry is becoming harder to ignore Alternate Club Health | flavor:60 Count trim

glp-1 receptor agonist antipsychotic weight gain study agonists are not just weight-loss drugs. They sit at the intersection of metabolism, inflammation, neuroplasticity, and cognition. That is why their relevance to metabolic psychiatry is becoming harder to ignore Alternate Club Health | flavor:60 Count trim

Alternate Club Health | TikTok

At each step in the shared decision-making process, clinicians need to identify a motivation for the patient to lose weight, according to Barbara Eichorst, MS, RD, CDCES, vice president of health care programs at the American Diabetes Association

trim

flavor:60 Count

Back Dushay, J (15 Sept 2023) 'How the Wegovy shortage is making life impossible for my patients — and for me', STAT News